A proposed Hodgkin’s lymphoma treatment returned positive test results in a clinical trial, according to drugmaker Seattle Genetics Inc., which seeks to file the drug for approval with the U.S. Food and Drug Administration next year.
Continue reading Seattle Genetics Gets Positive Results From Lymphoma Treatment Tests
Seattle Genetics Gets Positive Results From Lymphoma Treatment Tests originally appeared on DailyFinance on Tue, 28 Sep 2010 00:33:00.
Filed Under: Company News, Technology, Health Care